Single Domain Antibodies in the Development of Immunosensors for Diagnostics
Overview
Authors
Affiliations
Scientific advances in nanotechnology and nanoscience have enabled stability optimization and signal amplification in immunoassays by taking advantage of unique properties of nanomaterials. Biosensors based on antibodies and their fragments, also called immunosensors, are compact tools capable of providing refined antigen detection capacity. Different immunoassays that utilize these molecules for biorecognition have been used as diagnostic tools. In this regard, camelid single domain antibodies fulfill several requirements, such as nanometric size, high affinity, specificity, solubility, stability, biotechnological versatility, and low cost of production, constituting an important source for the development of immunodiagnostic devices. In this review, the main technological advances involving this specific class of molecules, as well as their major biotechnological applications will be addressed, with emphasis on their use as biosensors applied to diagnostics in human health.
Guelman S, Huang C, Peng K AAPS J. 2025; 27(1):37.
PMID: 39900849 DOI: 10.1208/s12248-025-01029-6.
El Salamouni N, Cater J, Spenkelink L, Yu H FEBS Open Bio. 2024; 15(2):236-253.
PMID: 38898362 PMC: 11788755. DOI: 10.1002/2211-5463.13850.
Yang H, Qi M, He Q, Hwang S, Yang J, McCoy M J Pharm Anal. 2023; 13(9):1013-1023.
PMID: 37842656 PMC: 10568103. DOI: 10.1016/j.jpha.2023.05.006.
Arce L, Pavan M, Bok M, Gutierrez S, Estein S, Tammone Santos A Sci Rep. 2023; 13(1):15448.
PMID: 37723180 PMC: 10507121. DOI: 10.1038/s41598-023-41955-z.
Large-Scale Production of Anti-RNase A VHH Expressed in Auxotrophic .
Karaman E, Eyupoglu A, Mahmoudi Azar L, Uysal S Curr Issues Mol Biol. 2023; 45(6):4778-4795.
PMID: 37367053 PMC: 10297652. DOI: 10.3390/cimb45060304.